- PR Newswire•2 days agoJohnson & Weaver, LLP Initiates Investigations of Bellerophon Therapeutics, Inc., KemPharm, Inc., Neos Therapeutics, Inc., CommVault Systems, Inc. and Resource Capital Corp.
Johnson & Weaver, LLP, is investigating potential violations of federal and state laws by certain officers and directors of Bellerophon Therapeutics, Inc. (BLPH). On February 13, 2015, Bellerophon's sold 13 million shares of stock in its initial public stock offering (the "IPO"), raising $60.0 million in new capital. However, since the IPO, Bellerophon's stock has imploded, on October 25, 2016, the stock closed at $1.40.
- PR Newswire•2 days ago
TINTON FALLS, N.J., Oct. 26, 2016 /PRNewswire/ -- Commvault (CVLT), a global leader in enterprise backup, recovery, archive and the cloud, today announced that its Chief Financial Officer, Brian Carolan, was named winner of the Best Growth Manager category for the 2016 NJBIZ CFO of the Year awards program. "We are proud that the New Jersey business community has acknowledged Brian's exemplary role as a successful corporate financial steward with this award," said Robert N. Hammer, chairman, president and CEO of Commvault.
- Forbes•2 days ago
Building on the trend toward Software-Defined everything, Bob Hammer, CEO of Commvault, is promoting a vision of Software-Defined Data Services that may ultimately disrupt one of the most stable areas of enterprise computing, persistent storage. While this sounds like just another acronym, if you dig in a bit, what Hammer is proposing is a new way for companies to organize their information, one that fits neatly into the points made by the concept of the data lake, the scale-out storage of HDFS, and the theory of technology evolution proposed by Ray Kurzweil, the legendary inventor and futurist....
CommVault Systems, Inc. (CVLT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Day's Range||54.39 - 55.99|
|52wk Range||29.41 - 56.29|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||316.98|
|Avg Vol (3m)||345,304|
|Dividend & Yield||N/A (N/A)|